For 2026, CMS GUIDE dementia quality measures now affect program payment for the first time, and Medicare families should watch medication safety, daily quality of life, and caregiver strain. GUIDE is CMS's voluntary test program that supports people with dementia and their unpaid caregivers. Performance Year 2026 began July 1, 2026. According to Elli Cares, it is the first year all five measures can adjust payment, moving the monthly care payment up 10% or down 3.5% read the Elli Cares analysis.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Official resources:
- Register through Helpdementia’s official page — Use this page to review requirements and register directly.
- Register through Cgsmedicare’s official page — Use this page to review requirements and register directly.
Table of Contents
- What changed for 2026?
- What do the five measures track?
- Who can join GUIDE?
- What does respite cover?
- What limits should families watch?
What changed for 2026?
CMS published Performance Measurement Manual v3.0 on May 18, 2026. According to Elli Cares, the manual replaced clinic-reported high-risk-medication reporting with claims-based measurement and updated the quality-of-life and caregiver measures read the Elli Cares analysis. That shift matters for families. Clinics are now judged on prescriptions that appear in Medicare claims.
Results should better reflect drugs patients actually received. Payment is also tied more directly to results. Strong measure scores can raise the monthly Dementia Care Management Payment. Weak scores can lower it.
What do the five measures track?
The five 2026 measures cover medication safety, well-being, caregiver impact, cost, and nursing-home use. Medication safety focuses on high-risk drug use in adults 67 and older, including antipsychotics and benzodiazepines. Patient quality of life is measured with PROMIS-10, a short health survey.
Caregiver impact is measured with the 22-item Zarit interview, which asks about stress and burden. The other two measures track total per-person cost and nursing-home admissions. Together they reward safer prescribing, better daily life, supported caregivers, and fewer avoidable facility moves.
Who can join GUIDE?
GUIDE only enrolls Traditional fee-for-service Medicare beneficiaries with confirmed dementia who live in the community. It excludes Medicare Advantage members, long-term nursing-home residents, and memory-care-unit residents. Families cannot join through Medicare generally.
They must find and enroll through a local participating GUIDE provider. About 330 organizations were approved as participants in CMS's July 8, 2025 announcement, according to CGS Medicare see the CGS Medicare notice. Ask a clinic whether it is an active GUIDE participant before seeking services.
What does respite cover?
GUIDE includes respite funding for eligible patients. The amount is up to about $2,500 per patient per year, rising to about $2,625 for the year starting July 2026. There is no patient cost-sharing for this benefit.
In-home respite is included. For caregivers, that can mean scheduled relief at home. Ask the GUIDE provider how it schedules respite, what hours are available, and how unused funds are tracked.
What limits should families watch?
GUIDE is a time-limited pilot running July 1, 2024 through June 30, 2032. Services may change or end after the test period. Prevention is another gap.
The Alzheimer's Association told CMS on Sept. 14, 2026 that dementia measures for obesity, exercise, sleep, nutrition, and head injury still do not exist. Families seeking help with brain-health prevention will not find those actions measured in GUIDE yet.
